BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30227356)

  • 41. Targeted Metabolomics for Plasma Amino Acids and Carnitines in Patients with Metabolic Syndrome Using HPLC-MS/MS.
    Gong LL; Yang S; Zhang W; Han FF; Xuan LL; Lv YL; Liu H; Liu LH
    Dis Markers; 2020; 2020():8842320. PubMed ID: 32733621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans.
    Thieme U; Schelling G; Hauer D; Greif R; Dame T; Laubender RP; Bernhard W; Thieme D; Campolongo P; Theiler L
    Drug Test Anal; 2014; 6(1-2):17-23. PubMed ID: 24424856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of Metabolites in Plasma, Urine and Feces of Healthy Participants after Taking Brahmi Essence for Twelve Weeks Using LC-ESI-QTOF-MS Metabolomic Approach.
    Minale G; Saesong T; Temkitthawon P; Waranuch N; Nuengchamnong N; Chootip K; Kamkaew N; Kongbangkerd T; Engsuwan J; Ingkaninan K
    Molecules; 2021 May; 26(10):. PubMed ID: 34063409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization.
    Peng M; Liu L; Jiang M; Liang C; Zhao X; Cai Y; Sheng H; Ou Z; Luo H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():12-8. PubMed ID: 23816563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.
    Ji H; Liu Y; He F; An R; Du Z
    J Pharm Biomed Anal; 2018 Jul; 156():104-115. PubMed ID: 29698861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry.
    Tsutsui H; Maeda T; Min JZ; Inagaki S; Higashi T; Kagawa Y; Toyo'oka T
    Clin Chim Acta; 2011 May; 412(11-12):861-72. PubMed ID: 21185819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolomic profile of arterial stiffness in aged adults.
    Koh AS; Gao F; Liu J; Fridianto KT; Ching J; Tan RS; Wong JI; Chua SJ; Leng S; Zhong L; Keng BM; Huang FQ; Yuan JM; Koh WP; Kovalik JP
    Diab Vasc Dis Res; 2018 Jan; 15(1):74-80. PubMed ID: 28976207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry.
    Hušek P; Švagera Z; Hanzlíková D; Řimnáčová L; Zahradníčková H; Opekarová I; Šimek P
    J Chromatogr A; 2016 Apr; 1443():211-32. PubMed ID: 27012787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolite profiling of plasma and urine from rats with TNBS-induced acute colitis using UPLC-ESI-QTOF-MS-based metabonomics--a pilot study.
    Zhang X; Choi FF; Zhou Y; Leung FP; Tan S; Lin S; Xu H; Jia W; Sung JJ; Cai Z; Bian Z
    FEBS J; 2012 Jul; 279(13):2322-38. PubMed ID: 22520047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitivity improvement in hydrophilic interaction chromatography negative mode electrospray ionization mass spectrometry using 2-(2-methoxyethoxy)ethanol as a post-column modifier for non-targeted metabolomics.
    Koch W; Forcisi S; Lehmann R; Schmitt-Kopplin P
    J Chromatogr A; 2014 Sep; 1361():209-16. PubMed ID: 25160955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Solid-phase extraction and nanoflow liquid chromatography-nanoelectrospray ionization mass spectrometry for improved global urine metabolomics.
    Chetwynd AJ; Abdul-Sada A; Hill EM
    Anal Chem; 2015 Jan; 87(2):1158-65. PubMed ID: 25521704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantification of Free Carnitine and Acylcarnitines in Plasma or Serum Using HPLC/MS/MS.
    Scott D; Heese B; Garg U
    Methods Mol Biol; 2016; 1378():11-9. PubMed ID: 26602112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolomic study of the intervention effects of Shuihonghuazi Formula, a Traditional Chinese Medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MS.
    Bao Y; Wang S; Yang X; Li T; Xia Y; Meng X
    J Ethnopharmacol; 2017 Feb; 198():468-478. PubMed ID: 28108381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders.
    Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new metabolomics-based strategy for identification of endogenous markers of urine adulteration attempts exemplified for potassium nitrite.
    Steuer AE; Arnold K; Schneider TD; Poetzsch M; Kraemer T
    Anal Bioanal Chem; 2017 Oct; 409(26):6235-6244. PubMed ID: 28815274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility of electroextraction as versatile sample preconcentration for fast and sensitive analysis of urine metabolites, demonstrated on acylcarnitines.
    Lindenburg PW; Tjaden UR; van der Greef J; Hankemeier T
    Electrophoresis; 2012 Oct; 33(19-20):2987-95. PubMed ID: 23001993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary metabonomic study of patients with acute coronary syndrome using UPLC-QTOF/MS.
    Wang Y; Sun W; Zheng J; Xu C; Wang X; Li T; Tang Y; Li Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():122-130. PubMed ID: 30316136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolomic profile of systemic sclerosis patients.
    Murgia F; Svegliati S; Poddighe S; Lussu M; Manzin A; Spadoni T; Fischetti C; Gabrielli A; Atzori L
    Sci Rep; 2018 May; 8(1):7626. PubMed ID: 29769578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic profiles revealed anti-ischemia-reperfusion injury of Yangxinshi tablet in Rats.
    Zhang H; Zhao Y; Xia Z; Du H; Gao Y; Xue D; Zhu Z; Chai Y
    J Ethnopharmacol; 2018 Mar; 214():124-133. PubMed ID: 28889959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.